1. SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY. (17th June 2021) Authors: Lim, S.H.; Campbell, N.; Joseph‐Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; Falconer, J.; Fox, C.; Collins, G.; O'Callaghan, A.; Willimott, V.; Ahearne, M.; Faust, S.N.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗